Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variantsTingting Li, Aishun Jin, Xiaojian Han et al.|Nature Communications|2021Cited by 51
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2Xiaojian Han, Aishun Jin, Yingming Wang et al.|Frontiers in Immunology|2021Cited by 34
A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBDXiaojian Han, Aishun Jin, Yingming Wang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 12
Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutationsMeiying Shen, Aishun Jin, Tong Zhang et al.|Cancer Immunology Immunotherapy|2024Cited by 10
A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBDTingting Li, Aishun Jin, Xiaojian Han et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 7